Dexcom's Charts Don't Make a Convincing Case for Its Shares

The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.

Will Powell Help Keep an Oversold Bounce Going?

The Fed chairman is speaking before the Senate here on Tuesday and again could impact the direction of the market.

Monday Reversal, Powell on the Hill, Macro Watch, Trading Lockheed and Northrop

The outright removal of potential liquidity from the economy earlier than expected scares the living heck out of everyone who understands.

Not Everyone Is United on Their View of UNFI

Let's look at my take on United Natural Foods vs. Value Line's take.

Monday's Big QQQ-uestion

Let's look at the move in the Invesco QQQ Trust and where it could go from here.

New Year, Same Old Market

We haven't moved past the either/or market -- and here's what that means for big-cap tech and growth stocks and breadth. Also, let's look at something shiny and precious.

Disgust, Despair, a Dash Upward and More Disappointment

Despite the intraday recovery, we had more poor action, and now it's all eyes on the Fed's chat with Congress.

Tilray Isn't Going to Get That High

TLRY posted promising earnings, but don't expect it smoke past its current levels for long.

Fastly Is Still Searching for a Bottom on the Charts

Let's review the charts and indicators.

One Simple Piece of Advice for Dealing With a Very Ugly Market

Traders often feel frozen when faced with a market like this. Here's a way to overcome inertia.